Search for: "Amgen Inc. v. Sanofi"
Results 61 - 80
of 110
Sort by Relevance
|
Sort by Date
16 May 2022, 12:16 pm
Qualcomm Incorporated (licensee appellate standing) and Amgen Inc. v. [read post]
21 Apr 2022, 10:07 am
Scope and Procedure for the Enablement Requirement: Amgen Inc., et al. v. [read post]
24 Feb 2022, 6:12 pm
” Full Scope Enablement: Amgen v. [read post]
8 May 2021, 10:26 pm
The panel will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc. v. [read post]
2 May 2021, 1:41 pm
PatentlyOreported on the case of Amgen Inc. v. [read post]
29 Apr 2021, 6:39 am
Amgen v. [read post]
19 Apr 2021, 6:04 am
by Dennis Crouch Amgen Inc. v. [read post]
21 Feb 2021, 9:59 pm
Noonan -- A little less than four years ago, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
19 Feb 2021, 2:28 am
In its latest decision on this topic, Amgen Inc. et al. v. [read post]
16 Feb 2021, 7:57 pm
by Dennis Crouch Amgen v. [read post]
31 May 2020, 9:00 pm
Sanofi; Janssen Biotech, Inc. v. [read post]
30 Jan 2019, 9:19 pm
Sanofi, overturning application of the written description precedent of Noelle v. [read post]
16 Jan 2019, 9:42 pm
Noonan -- The Supreme Court denied certiorari last week in Amgen Inc. v. [read post]
3 Oct 2018, 8:51 am
Amgen Inc. v. [read post]
23 Aug 2018, 9:10 am
” Amgen Inc. v. [read post]
9 Aug 2018, 5:16 pm
” Amgen Inc. v. [read post]
28 Feb 2018, 9:35 pm
The memorandum, entitled "Clarification of Written Description Guidance For Claims Drawn to Antibodies and Status of 2008 Training Materials," is divided into three sections, which address the Federal Circuit's recent decision in Amgen Inc. v. [read post]
19 Nov 2017, 9:05 pm
Noonan -- Last month, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
17 Oct 2017, 6:09 pm
Judge Robinson had concluded that the patent was valid, and applied the test articulated in eBay Inc. v. [read post]
6 Oct 2017, 2:34 pm
Finding for Sanofi, the court held the sentence to be improper, relying heavily on its decision in Centocor Ortho Biotech, Inc. v. [read post]
